SCHEMBL20910598

SCHEMBL20910598

Fc1c(-c2sc3cc4c(cc3c2F)sc2c3cc5sc(-c6sc7ccccc7c6F)c(F)c5cc3sc42)sc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.40
▸ MAPT P10636 6/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TNKS O95271 2/20 0.33
▸ TNKS2 Q9H2K2 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ LIMK1 P53667 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ HCRTR1 O43613 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20910599 0.95 GPR3 (0.39) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL20910597 0.87 MAPT (0.32) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL20910621 0.83 MAPT (0.33) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL20910600 0.83 MAPT (0.31) GPR3MAPT
SCHEMBL752698 0.80 GPR3 (0.55) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL20910622 0.80 MAPT (0.33) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL23917094 0.77 GPR3 (0.50) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL14925153 0.77 GPR3 (0.64) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL20910603 0.76 — —
SCHEMBL24068028 0.75 GPR3 (0.61) GPR3MAPTALDH1A1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11242357-B2 Fused polycyclic heteroaromatic compound and organic thin film and electronic device SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-02-08 — — US disclosed
US-20190112319-A1 FUSED POLYCYCLIC HETEROAROMATIC COMPOUND AND ORGANIC THIN FILM AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-04-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11242357-B2 Fused polycyclic heteroaromatic compound and organic thin film and electronic device TET1, SLC43A1, OCIAD1 GPR3 4396/4885MAPT 1235/4885ALDH1A1 1133/4885
US-20190112319-A1 FUSED POLYCYCLIC HETEROAROMATIC COMPOUND AND ORGANIC THIN FILM AND ELECTRONIC DEVICE TET1, SLC43A1, OCIAD1 GPR3 4396/4885MAPT 1235/4885ALDH1A1 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback